AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HDTRA114C0003ANACOR PHARMACEUTICALS, INC.
Overview
Award facts
- Net obligations
- $7.78M
- $7,777,953of $13.64M potential value
- Period of performance
- Oct 16, 2013 to Nov 30, 2015
- Ended
- Modifications
- 7
- Latest action Feb 26, 2020
- Contract type
- Definitive contract
- PIID HDTRA114C0003
Description of requirement
IGF::OT::IGF OVERCOMING RESISTANCE BY THE APPLICATION OF BORON TO RIBOSOMAL INHIBITORS
Dates and value
- Award date
- Signed on Oct 16, 2013
- Potential end of performance
- Nov 29, 2015
- Current value
- $7,909,191Base and exercised options
- Potential value (if all options are exercised)
- $13,644,261
Obligations by fiscal year of action
- FY2020: -$131,238 (de-obligation)
- FY2015: $148,934
- FY2014: $7,760,257
Total across 3 fiscal years: $7,777,953
Net de-obligation in that fiscal year (obligations withdrawn).
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 20, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 26, 2020. View on USAspending · Recipient on SAM.gov
Recipient
LocationNEW YORK, NY
UEIHGNKDH1DLM86
CAGE code3AYC5
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyPFIZER INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Defense Contract Management Agency
- DCMA NORTHEAST (GARDEN CITY)
- Funded by
- Department of Defense
- Defense Threat Reduction Agency
Place of performance
- Place of performance
- New York, New York 10017-5703
- Congressional district (place of performance)
- NY-12As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN92R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 3
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Oct 16, 2013Base obligation at award: $2,756,968
- Latest action
- Feb 26, 2020 — Funding onlyModification A00001; obligation change -$131,238; funding only: changes obligations, not scope
- Latest substantive action
- Aug 8, 2014 — Option exercisedModification P00002; obligation change +$5,003,289
- Latest funding action
- Feb 26, 2020 — Funding onlyModification A00001; obligation change -$131,238; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action4
- Funding only1
- Option exercised1
- Vendor address change1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
- Sea transportation
- UnknownU
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- DoD claimant program
- All others not identifiable to any other procurement programC9E
- Awarding agency code
- 9700
- Awarding sub-tier code
- 9763
- Contracting office code
- S3309A
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 9761
- Funding office code
- HDTRA1